Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,066,917
-
Share change
-
+12,995,735
-
Total reported value
-
$1,574,456,699
-
Put/Call ratio
-
104%
-
Price per share
-
$92.27
-
Number of holders
-
86
-
Value change
-
+$1,182,605,228
-
Number of buys
-
84
-
Number of sells
-
2
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q3 2017
As of 30 Sep 2017,
CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,066,917 shares.
The largest 10 holders included
Capital Research Global Investors, Invesco Ltd., BAILLIE GIFFORD & CO, FMR LLC, FIL Ltd, Bank of New York Mellon Corp, Artisan Partners Limited Partnership, BlackRock Inc., HERMES INVESTMENT MANAGEMENT LTD, and Hillhouse Capital Management, Ltd..
This page lists
86
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.